http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105833302-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-221 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
| filingDate | 2016-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105833302-B |
| titleOfInvention | A kind of contrast agent and preparation method thereof |
| abstract | The present invention provides a kind of contrast agent and preparation method thereof, are related to field of medical technology.The contrast agent is mainly prepared from the following raw materials, according to parts by weight: 2~4 parts of diphenyl phosphate azide, 8~12 parts of dipalmitoylphosphatidylcholine, phosphatidase 3~5 part, 2.5~3.5 parts of cholesterol, 1.5~2.5 parts of melanin and 8~15 parts of perfluoropropane, phosphatide is PEGylated phosphatide.The good biocompatibility of contrast agent provided by the invention, and have no toxic side effect, contrasting effects might as well.The production method step of contrast agent provided by the invention is simple, easy to operate. |
| priorityDate | 2016-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.